Spontaneous T cell leukemias in AKR and HRS[J mice produce recombinant retroviruses that contain no known oncogene sequences (1), yet cause leukemia even when injected into mice with a low incidence of the disease (2). The transforming mechanism of these viruses is unknown, but an important early event in the process is the binding of the viral envelope glycoprotein, gp70, to receptors of the target cell (3-7). This interaction most likely permits entry of the virus into the cell. Binding characteristics of retroviruses have been demonstrated in several models (3) (4) (5) (8) (9) (10) and candidate receptor molecules have been isolated (11-16).
incubated overnight at 4°C. The wells were then washed four times with 1% BSA-PBS-A and 100 el of substrate solution (20 ml 0.05 M NaHCOs, pH 9.5, 0.02 M MgCI~, and four substrate tablets [Sigma Chemical Co.]) was added to each well. The optical density (A4o5) was read on an ELISA spectrophotometer (Dynatech Laboratories, Inc.).
Antiidiotypic Antisera. New Zealand White rabbits were immunized subcutaneously with an initial injection of 500 #g of anti-P1 gpT0 monoclonal antibody (referred to as 1416) in complete Freund's adjuvant and subsequently boosted twice at 2-wk intervals with 500 #g of same antibody in an emulsion of incomplete adjuvant. The sera obtained were extensively absorbed on pooled mouse Ig (Cappei Laboratories, Cochranville, PA), followed by mouse IgG2a and IgG2b coupled to Sepharose 4B (Pharmacia Fine Chemicals). When no further protein could be eluted from these immunoadsorbants with 0.5 N acetic acid, the flow-through was adsorbed to and eluted from 5 mg of affinity-purified 1416 coupled to Sepharose 4B. The eluate was concentrated, dialyzed against PBS-A, and stored at 4°C until used.
Radioimmunoassay (RIA).
Two types of RIA were used: (a) an indirect RIA measured 1416 idiotype binding to the antiidiotype, and (b) a competitive RIA measured Ig or virus inhibition of 1416 idiotype binding to the antiidiotype. For both types of RIA, polystyrene tubes (12 x 75 ram) were coated with 250 ng of the the antiidiotype in 100 #l of PBS-A, and incubated overnight at 4°C. The tubes were then blocked with 5% BSA-PBS-A for 2 h at 37°C. For the indirect RIA, this step was followed by the addition of 100 #! of the idiotype (1416) or other Ig diluted in 1% BSA-PBS-A. The tubes were incubated for 6 h at 4°C, washed three times with 1% BSA-PBS-A, and 100 #1 of ~25I-labeled rabbit antimouse Ig (105 cpm) diluted in 1% BSA-PBS-A was added. After an overnight incubation at 4°C, the tubes were washed four times and counted in an Auto Gamma Counter 4000 (Beckman Instruments, Inc., Fullerton, CA). All determinations were performed in triplicate. For the competitive RIA, two methods were used. In experiments to determine Ig inhibition of idiotype binding to the antiidiotype, 50 #i of ~25I-labeled 1416, in a concentration previously determined to be limiting for binding to the antiidiotype, was added to 50 #1 of Ig. This mixture was immediately added to antiidiotype-coated tubes that were prepared and blocked as stated above. After overnight incubation at 4 o C, the tubes were washed four times with 1% BSA-PBS-A and counted. For assays to evaluate virus inhibition of idiotype binding to antiidiotype, 100 ng of 1416 in 50 ~! 1% BSA-PBS-A was preincubated with 50 #1 of purified virus for 2 h at 4°C. The antibody-virus mixture was then added to antiidiotype-coated tubes that were prepared and blocked as before. After incubation for 6 h at 4 o C, the tubes were washed three times with 1% BSA-PBS-A, and 105 cpm of l~5I-labeled rabbit anti-mouse Ig was added. The tubes were then incubated overnight at 4°C, washed four times, and counted.
Immune Precipitation Assays. Anti-P1 virus monoclonal antibodies were screened for binding to viral gpT0 by immune precipitation with both radiolabeled purified virus preparations and membrane lysates from virus-infected cells. For immune precipitation with viral proteins, 25 t~g of purified virus solubilized in PBS containing 0.5% Nonidet P-40 (NP-40) was radiolabeled with 0.6 mCi Na~5I (Amersham Corp., Arlington Heights, IL) using Iodobeads (Pierce Chemical Co., Rockford, IL) according to the method of Markwell (34) . The solubilized virus preparation was precleared twice with normal mouse sera preadsorbed to Staph A (IgGsorb; The Enzyme Center, Inc., Boston, MA) and once with Staph A alone. 10 vg of affinity-purified antivirus monoclonal antibody was incubated overnight at 4°C with 2 x 106 cpm of the labeled virus lysate in a final volume of 100 ~1. 80 #1 of a 10% Staph A suspension was then added for I h, followed by four pellet washes with 0.1% BSA-PBS-A containing 0.5% NP-40. Immune precipitates were then eluted from the Staph A by incubation at 100°C for 5 min in sample buffer (0.06 M Tris-HCl, 10% glycerol, 3% sodium dodecyl sulfate (SDS), 0.02% bromphenol blue, with or without 5% 2-mercaptoethanol).
For immune precipitation with cell membrane lysates, 2 x 107 cells were radiolabeled with 1.0 mCi Na~25I by the lactoperoxidase technique (35) . Cells were washed four times before and immediately after labeling with ice-cold PBS, and then lysed in 300/A of 0.01 M Tris-HCI, 0.15 M NaCI, 0.5% NP-40, 2 mM phenylmethylsulfonyl fluoride, pH 7.0, for V2 h on ice. The lysate was twice centrifuged at 13,000 rpm for 45 min at 4°C in an Eppendorf centrifuge (Brinkmann Instruments Co., Westbury, NY) to remove cellular debris. The remaining supernatant was precleared and immune precipitated as above. When the antiidiotypic serum was used to immune-precipitate radiolabeled membrane lysates, preimmune rabbit serum and rabbit anti-mouse Ig were substituted for normal mouse serum in the preclearing procedure.
Polyacrylamide Gel Electrophoresis (PAGE). Immediately after elution from the Staph
A, the immune precipitates were analyzed by PAGE in 12.5% acrylamide slab gels, according to the method of Laemmli (36) . Gels were run at 150 V (constant voltage) at room temperature. Autoradiography was enhanced by the use of x-ray intensifying screens at -70°C.
Virus Protein Blotting. 10 #g of purified P 1 virus was added to 40 ttl of sample buffer (with 5% 2-mercaptoethanol) and heated for 5 rain at 100°C. The sample was then applied to a 12.5% acrylamide slab gel and electrophoresis was performed as above. Protein blotting was performed according to the method of Towbin et al. (37) for 4 h at 250 mA onto 0.45-#m pore nitrocellulose paper (Schleicher & Schuell, Inc., Keene, NH). The paper was blocked with 3% BSA-PBS-A/0.5% NP-40 for 2 h at 4°C and then soaked in hybridoma supernatant overnight at 4 o C, with slow, constant rotation. After six washes with 1% BSA-PBS-A/0.5% NP-40, the paper was soaked for 3 h at 4°C in a solution of l~5I-rabbit anti-mouse Ig (105 cpm/ml). The paper was then washed eight times as above, air dried, and autoradiographed for 24 h at -70°C with an x-ray intensifying screen.
Immunofluorescent Flow Cytometry. Murine leukemia cell lines and tumors were stained in suspension for analysis with a fluorescence-activated cell sorter (FACS IV; B-D Automated Immunochemistry, Becton, Dickinson & Co., Salt Lake City, UT). Cells were washed twice with cold PBS, pH 7.2, containing 0.5% heat-inactivated FCS and 0.02% sodium azide (FCS-PBS-A), and assayed for viability by trypan blue exclusion. Only cell suspensions demonstrating >90% viability were used. 5 #g anti-P1 gp70 monoclonal antibody or 2.5 #g antiidiotype diluted in 50 #1 of FCS-PBS-A were added to pellets containing 106 cells. The pellets were resuspended and incubated on ice for 30 min. Cells were washed once with cold FCS-PBS-A and incubated as before with 50 ~1 of a 1:30 dilution of fluorescein isothiocyanate-conjugated goat antiserum to mouse IgG (Meloy Laboratories, Inc., Springfield, VA) or rabbit IgG (Cappel Laboratories). The cell pellets were then washed once again with FCS-PBS-A and fixed in 1% formaldehyde before FACS analysis.
Results
Characterization of a Monoclonal Antibody to P1 gp70. Previous work (2, 17, 18, 38, 39) has shown that recombination within the envelope (env) region of the retroviral genome is responsible for the expression of novel gp70s in spontaneously generated leukemogenic viruses. Distinct gp70s have been demonstrated in three recombinant leukemogenic retroviruses (P1, P2, and P5) and in two nonleukemogenic viruses (ecotropic and xenotropic) isolated from HRS/ J mice (2) . Hence, a panel of these five purified viruses was used in a screening assay to detect monoclonal antibodies with specificity for the leukemogenic virus P1. Of all the antiretroviral monoclonal antibodies that were obtained after immunizing NFS/N mice with P1 virus-infected cells, one of them (1416) was found to bind to P1 virus but not to the P2, P5, ecotropic, and xenotropic isolates ( Fig. 1 ).
This monoclonal antibody was further characterized by SDS-PAGE of immunoprecipitates of lysates from radiolabeled purified virus, virus-induced thymic leukemia cells, and normal CBA/J thymocytes (Fig. 2) . A 70,000 (70 K) tool wt protein was immunoprecipitated from P1 by 1416, but not from P2 or ecotropic
OPTICAL DENSITY (A405) Characterization of an Antiidiotype Against Monoclonal Antibody 1416. An antiserum to antibody 1416 was raised by immunization of a rabbit. After extensive absorption (see Materials and Methods), the antiserum from this animal was found to recognize an idiotypic determinant of 1416. Fig. 3A illustrates that the antiidiotypic antiserum did not bind to normal pooled mouse Ig, normal NFS mouse serum, or to the myeloma protein MOPC-195, which has the same isotype (IgG2b) as 1416. Complete inhibition of 1416 binding to the antiidiotype was achieved with 1416 but not with MOPC-195, pooled mouse Ig, or NFS mouse serum, which contains Ig with the same allotypic determinants as 1416 (Fig. 3 B) . The P 1 virus specifically inhibited the binding of 1416 to the antiidiotype (Fig.  4) . In the presence of P 1 virus, the idiotype-antiidiotype interaction was completely inhibited when we used a protein concentration of virus 100-fold greater than that of the idiotype. Identical inhibition was seen when purified P1 gp70 was used as the inhibitor in 50-fold less quantities than the whole virus (data not shown). The specificity of the inhibition was shown by the failure of purified P2 virus to inhibit the reaction.
Binding of the Antiidiotype to Different Murine Leukemias. Immunofluorescence flow cytometry was used to assay the antiidiotypic serum for its ability to bind to leukemia cells. We did not observe the anticipated pattern of binding. Even though the idiotype (1416) bound to P 1 and not to P2 virus (Fig. 1 ), and to P 1 T h y and not to P2 T h y (Fig. 5B) , the antiidiotype bound to both P1 T h y and P2 T h y (Fig. 5A) . Possible explanations for the results with the antiidiotypic serum include: (a) the presence of two or more antibody populations with different antigen specificities in the antiidiotypic serum; (b) binding to virusencoded determinants present on the surface of both leukemias; and (c) recognition of a determinant that is shared by both P1 T h y and P2 Thy. T h e first possibility is unlikely because the antiidiotype was extensively absorbed with mouse Ig and then affinity purified on a 1416-Sepharose column (see Materials and Methods). Separate absorptions of the antiidiotype with four different leukemia cell lines greatly reduced its reactivity with P1 T h y (Fig. 6A) ; moreover, antiidiotype that was absorbed with P1 Thy cells lost its ability to bind to the 1416 idiotype, whereas absorption with normal CBA/J thymocytes did not affect its ability to bind to the 1416 idiotype (Fig. 6B) . The second possibility was excluded by immunoprecipitation studies as shown below.
The third possibility was explored by testing the reactivity of the antiidiotype with a panel of different murine leukemia cell lines. 14 spontaneous thymus leukemias from different AKR/J mice, one Abelson virus-induced "pre-B" cell leukemia (298-18), and one Friend virus complex-induced erythroleukemia (CL-85) were examined for antiidiotype binding by flow cytometry. Results of these experiments (Table I , column A) showed that the antiidiotype bound to several leukemia cell lines, including both T cell and non-T cell leukemias. A control preparation of normal rabbit Ig demonstrated no binding. Normal lymphoid cells from the murine strains in which these ieukemias were induced did not bind to the antiidiotype. Normal CBA/J thymocytes that were stimulated for either 48 or 96 h with concanavalin A (1 #g/(106 cells, mi) also failed to bind to the antiidiotype, indicating that the idiotype-like structure was not a proliferation antigen.
The idiotype (1416) also bound to some of these leukemia cell lines (Table I , column B). lmmunoprecipitation and SDS-PAGE analysis of [~5S]methioninelabeled AKR leukemia cell lysates confirmed that the structure recognized by 1416 was an 85 K mol wt protein (data not shown). Thus, an epitope common to the gp70 precursor of several of these independently derived tumors was also expressed on P1 Thy. Yet, as seen with P2 Thy, AKR 21, AKR 71, and pre-B 298-18, the lack of expression of this epitope (Table I, Moloney virus antiserum. By contrast, three bands with molecular weights of 70, 63, and 55 K were found in the precleared lysates of P1 T h y cells that were immunoprecipitated with the antiidiotype (Fig. 7 C, lane a) . Experiments with lysates from surface-labeled P2 T h y cells yielded identical results (data not shown).
T h r e e other leukemia cell lines (pre-B 298-18, Friend CL-85, AKR-71) were also surface-labeled with 125I and the cell lysates immunoprecipitated as above. Protein bands c o m m o n to all three leukemias were found in the lanes containing the antiidiotype immune precipitates (Fig. 8) ; as with the P1 T h y cells, 70 and 55 K mol wt proteins were also precipitated from these three leukemia cell lysates (Fig. 8, lanes d, h, l) and the 63 K mol wt protein was seen in two of them. A less prominent 25 K moi wt band in these three leukemia lines was not detected in the P1 T h y immunoprecipitates. Several other bands were noted in Fig. 8,  lanes d, h, and l ; the possibility that all or some of these were the result o f coprecipitation remains to be clarified. (15) detected a 14 K protein on C57BL/6 mouse spleen cell membranes that bound a Friend virus glycoprotein complex (gp85). We have performed similar experiments with thymic leukemias. In our hands, however, pretreatment of cell membranes with a bifunctional crosslinking chemical followed by immunoprecipitation with a monoclonal anti-gp70 antibody only occasionally yielded cellular proteins distinct from endogenous gp85. We also found that without the use of a crosslinking reagent, no proteins coprecipitated with gp85 (unpublished data).
Because of our lack of success with this technique, we used a different approach, based on the idea that cell surface receptors can share binding determinants with anti-ligand antibodies (23) (24) (25) (26) (27) (28) . In retrovirus-induced murine T cell leukemia, the viral envelope glycoprotein gp70 serves as the ligand to which the target cell receptor binds. Hence, the variable region of an anti-gp70 antibody may resemble the binding region ofa retroviral receptor. In principle, therefore, the combining sites of both the receptor and the antibody may be identified by an appropriate antiidiotypic antibody.
A monoclonal antibody that recognized the gp70 of a cloned recombinant leukemogenic polytropic retrovirus termed P1 was the starting point for the present experiments. This antibody (1416) was selected because it failed to react with endogenous ecotropic and xenotropic viruses, and it did not bind to two other recombinant viruses, P2 and P5, with structurally different gp70s (2) . In subsequent studies, however, we found that 1416 was reactive with several other virus-induced leukemia cell lines (Table I) . Thus, despite its specificity for the gp70 of the P1 virus, this monoclonal antibody crossreacted with other retroviruses, presumably because of shared epitopes in their gp70s.
Antibody 1416 was used to prepare a rabbit antiidiotypic antiserum. This antiserum reacted with structures in or near the antigen-binding site of 1416, as determined by inhibition of the idiotype-antiidiotype reaction by the P1 virus (Fig. 4) . The inhibition was specific, as another cloned leukemogenic polytropic retrovirus (P2) did not affect the reaction.
The antiidiotypic reagent failed to react with normal murine lymphoid cells when it was tested by both immunofluorescence and immunoprecipitation methods. Furthermore, mitogenic stimulation of thymocytes from 4-wk-old normal CBA/J mice failed to induce a significant expression of the idiotype-like determinant, suggesting that it is not a widely expressed proliferation antigen. The failure of the antiidiotype to react with normal thymocytes suggests that the idiotype-like structure we found is leukemia specific. Alternatively, the structure might occur on only a few undetectable normal cells that are targets for the retrovirus. After infection and transformation, such cells would increase in number and thus become readily detectable in the leukemia cell population.
The antiidiotypic serum reacted with a structure on the surface of a murine thymic leukemia (P1 Thy) that was induced by the retrovirus (P1) against which the anti-gp70 antibody (1416) was raised. This membrane determinant, however, was also found on several different murine leukemias, irrespective of the serological relatedness of their expressed retroviral glycoproteins to P1 gp70. For example, the leukemia cell lines pre-B 298-18, AKR-65I, and AKR-71 reacted strongly with the antiidiotype, but failed to bind to 1416 (Table I) .
The data thus indicate that the membrane structure detected by the antiidiotype is not virally encoded. Additional evidence against its viral origin is the failure of an anti-Moloney virus antiserum (which crossreacted with P1 viral proteins) to eliminate the structure from labeled P1 Thy membrane lysates, whereas the same antiserum removed most virus-encoded proteins from the lysates (Fig. 7C) . The determinant is not an artifact caused by adsorption of mouse Ig to the surface of the murine leukemia cells that had been passed in vivo; it was found not only on leukemia cells obtained ex vivo (P1 Thy, P2 Thy) but also on leukemia cell lines maintained exclusively in vitro. Furthermore, membrane lysates of labeled leukemia cells that were precleared with rabbit antimouse Ig still contained the idiotype-bearing structure (Figs. 7 C, 8) .
If the anti-(anti-gp70) idiotype we describe indeed identifies a retroviral receptor, then receptors for different leukemogenic viruses may share common structures. This possibility is strengthened by the finding that different leukemia cell lines, regardless of their lineage or causative retrovirus, expressed a similar membrane structure. However, since Ig with different binding specificities are known to share idiotypes (41, 42) , it is possible that the binding specificities of gp70 receptors may be unique despite their shared reactions with the antiidiotype. The polyclonal antiidiotypic serum used in our experiments increased the likelihood that a family of idiotypic determinants, rather than a single idiotope, was recognized. It is also possible that the antiidiotype was an "internal image" (homobody) (43) of the gp70 of P1, but only to an approximation, so that the specific features of the recombinant gp70 were imprecisely mirrored by the binding site of the antiidiotype. The above factors could explain the broad range of reactivity among the several leukemias examined with the antiidiotype. Hence, the concept that retroviral receptors share common structures and yet possess unique virus-binding specificities is not internally inconsistent.
McGrath et al. (28) have also studied receptors for retroviruses on leukemic cells. They found that the surface IgM of a murine B cell lymphoma bound to a ieukemogenic retrovirus, and that antibodies against the idiotype of the surface IgM inhibited its binding to the virus. Fluorescence analysis indicated that the idiotype of the B cell lymphoma was also present on two T cell lymphomas.
Nepom et ai. (26) showed that an anti-reovirus hemagglutinin idiotype was shared by lymphoid and nonlymphoid (neural) cells, both of which are targets of the reovirus. In the same system, Kauffman et al. (44) demonstrated that a monoclonal anti-antihemagglutinin idiotypic antibody is capable of blocking virus binding to idiotype-positive cells.
If anti-(anti-gp70) idiotypic antibodies are capable of binding to retroviral receptors in vivo, then interference with primary infection, subsequent viral propagation, or inhibition of leukemia cell proliferation may be anticipated. The binding of antiidiotypic antibodies to retroviral receptors might also initiate mitogenic signals similar to those postulated for gp70, and result in lymphoblastic transformation (17, 45) , lymphokine sensitivity (46), or both. Inhibition of virus binding to a murine thymoma by monoclonal anti-T cell antibodies has been shown to prevent tumor cell proliferation in vitro (47) . Those antibodies, however, were not specific for leukemia cells but bound to normal T cell antigens such as Thy-1. The effects of antiidiotypic reagents on these processes may provide insights into the specific events involved in viral leukemogenesis at the level of the cell membrane. Finally, diagnostic application of the kind of antiidiotype we have described, a topic currently under investigation, could lead to a novel way of identifying leukemic cells.
Summary
The possibility that receptors for retroviral gp70 share structural elements with the antigen-binding sites of anti-retroviral gp70 antibodies was investigated.
A monoclonal antibody (1416) was produced that reacted with the gp70 of a cloned recombinant leukemogenic retrovirus, termed P1. An antiidiotypic antiserum raised to 1416 was tested for its ability to bind to the thymic leukemia induced by P1 (P1 Thy). A membrane structure was identified on the surface of P 1 Thy that reacted with the antibody against the idiotypic determinant of 1416. A similar structure was identified on the surface of several different, independently derived murine leukemias of T cell, B cell, and erythroid lineage. The expression of the idiotype-like determinant on these leukemia cells was independent of the serological relatedness of their expressed retroviral envelope glycoproteins to P1 gp70. The determinant recognized by the antiidiotype was not detected on normal lymphoid cells. The recognition by the anti-(anti-gp70) idiotype of determinants on unrelated murine leukemias suggests that receptors for different leukemogenic viruses may share common structures.
